The GABA-benzodiazepine receptor complex: Structure, function, and role in anxiety

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 2, 2005, Pages 14-20

  Roy Byrne, Peter P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ABECARNIL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DIAZEPAM; FLUMAZENIL; ZOLPIDEM TARTRATE;

ANXIETY; ANXIETY DISORDER; CHEMICAL MODIFICATION; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TOLERANCE; GENETIC VARIABILITY; HUMAN; NEUROANATOMY; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

ANIMALS; ANXIETY DISORDERS; BENZODIAZEPINES; HUMANS; RATS; RECEPTORS, GABA-A; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 14844295092     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci 2000;21:16-19
2. Smith TA. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br J Biomed Sci 2001;58:111-121
3. Vermetten E, Bremner JD. Circuits and systems in stress, pt 1: preclinical studies. Depress Anxiety 2002;15:126-147
4. Mohler HF, Crestani D, Rudolph U. GABA(A)-receptor subtypes: a new pharmacology. Curr Opin Pharmacol 2001;1:22-25
5. Barnard EA, Skolnick P, Olsen RW, et al. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998;50:291-313
6. Tallman JF, Casella J, Kehne J. Mechanism of action of anxiolytics. In: Davis KL, Charney D, Coyle JT, et al, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:993-1008
7. Chou KC. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. Biochem Biophys Res Commun 2004;316:636-642
8. Rudolph U, Crestani F, Benke D, et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999; 401:796-800
9. Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry 2003;64(suppl 3):21-27
10. Low K, Crestani F, Keist R, et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000;290:131-134
11. Vermetten E, Bremner J. Circuits and systems in stress, pt 2: applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 2002;16:14-38
12. Shah AA, Treit D. Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests. Brain Res 2004;996:31-40
13. Kaufmann WA, Humpel C, Alheid GF, et al. Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res 2003;964:91-99
14. Roy-Byrne PP, Cowley DS, Greenblatt DJ, et al. Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 1990;47:534-538
15. Roy-Byrne PP, Cowley DS, Radant A, et al. Benzodiazepine pharmacodynamics: utility of eye movement measures. Psychopharmacology (Berl) 1993;110:85-91
16. Cowley D, Roy-Byrne PP, Hommer D, et al. Benzodiazepine sensitivity in anxiety disorders. Biol Psychiatry 1991;29:57A
17. Roy-Byrne P, Wingerson DK, Radant A, et al. Reduced benzodiazepine sensitivity in patients with panic disorder, comparison with patients with obsessive-compulsive disorder and normal subjects. Am J Psychiatry 1996;153:1444-1449
18. Cowley DS, Roy-Byme PP, Greenblatt DJ, et al. Personality and benzodiazepine sensitivity in anxious patients and control subjects. Psychiatry Res 1993;47:151-162
19. Glue P, Wilson S, Coupland N, et al. The relationship between benzodiazepine sensitivity and neuroticism. J Anxiety Disord 1995;9:33-45
20. Nutt DJ, Glue P, Lawson C, et al. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990;47:917-925
21. Woods SW, Charney DS, Silver JM, et al. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 1991;36:115-127
22. Maddock RJ. Acute effects of low-dose flumazenil in panic disorder. J Clin Psychopharmacol 1998;18:258-261
23. Strohle A, Kellner M, Holsboer F, et al. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry 1999;45: 321-326
24. Kapczinski F, Curran HV, Gray J, et al. Flumazenil has an anxiolytic effect in simulated stress. Psychopharmacology (Berl) 1994;114:187-189
25. Ninan PT, Insel TM, Cohen RM, et al. Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science 1982;218:1332-1334
26. Dorow R, Horowski R, Paschelke G, et al. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet 1983;2:98-99
27. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 2001;179:390-396
28. Sangameswaran L, Fales HM, Friedrich P, et al. Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc Natl Acad Sci U S A 1986; 83:9236-9240
29. Mullen KD, Martin JV, Mendelson WB, et al. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1988;1:457-459
30. Zinder O, Dar DE. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta Physiol Scand 1999; 167:181-188
31. Strohle A, Romeo E, di Michele F, et al. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 2002;159:145-147
32. Hucklebridge F, Doyle A, Pang FY, et al. Regional and molecular separation of the four bioactivities of 'tribulin.' Neurosci Lett 1998;240:29-32
33. Ferrera P, Guidotti A, Conti-Tronconi B, et al. A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 1984;23:1359-1362
34. Malizia AL, Cunningham VJ, Bell CJ, et al. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998;55:715-720
35. Bremner JD, Innis RB, White T, et al. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000;47:96-106
36. Tiihonen J, Kuikka J, Rasanen P, et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder, a fractal analysis. Mol Psychiatry 1997;2:463-471
37. Bremner JD, Innis RB, Southwick SM, et al. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 2000;157:1120-1126
38. Goddard AW, Mason GF, Almai A, et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001;58:556-561
39. Crestani F, Lorez M, Baer K, et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999;2:833-839
40. Ramboz S, Oosting R, Amara DA, et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 1998;95:14476-14481
41. Caldji C, Diorio J, Anisman H, et al. Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice. Neuropsychopharmacology 2004;29:1344-1352
42. Iwata N, Cowley DS, Radel M, et al. Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry 1999;156:1447-1449
43. Feusner J, Ritchie T, Lawford B, et al. GABA(A) receptor beta 3 subunit gene and psychiatric morbidity in a post-traumatic stress disorder population. Psychiatry Res 2001;104:109-117
44. Hallstrom C, ed. Benzodiazepine Dependence. Oxford, England: Oxford University Press; 1993
45. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005;66(suppl 2):9-13
46. McLeod DR, Hoehn-Saric R, Labib AS, et al. Six weeks of diazepam treatment in normal women: effects on psychomotor performance and psychophysiology. J Clin Psychopharmacol 1988;8:83-99
47. Holt RA, Bateson AN, Martin IL. Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology 1996;35:1457-1463
48. Steppuhn KG, Schneider HH, Turski L, et al. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 1993;264:1395-1400
49. Follesa P, Cagetti E, Mancuso L, et al. Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not long-term treatment with, benzodiazepine full or partial agonists. Brain Res Mol Brain Res 2001;92:138-148
50. Allison C, Pratt JA. Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 2003;98:171-195
51. Cowley DS, Roy-Byme PP, Radant A, et al. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment. Neuropsychopharmacology 1995;12:147-157